The company specializes in neurodegeneration and tauopathies, focusing on diseases like Alzheimer's and Progressive Supranuclear Palsy (PSP). By researching tauopathies, which involve abnormal aggregation of hyperphosphorylated Tau proteins and inflammation, AlzProtect aims to provide drug candidates for the treatment of these conditions. From discovery to clinical trials, they are dedicated to developing effective therapies for neurodegenerative diseases, offering hope for patients suffering from Alzheimer's and orphan tauopathies.